Koninklijke Philips NV ADR (PHG)vsStryker Corporation (SYK)
PHG
Koninklijke Philips NV ADR
$26.25
-2.27%
HEALTHCARE · Cap: $27.08B
SYK
Stryker Corporation
$335.67
-1.20%
HEALTHCARE · Cap: $133.77B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 41% more annual revenue ($25.12B vs $17.83B). SYK leads profitability with a 12.9% profit margin vs 5.0%. PHG appears more attractively valued with a PEG of 0.36. SYK earns a higher WallStSmart Score of 67/100 (B-).
PHG
Hold49
out of 100
Grade: D+
SYK
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-340.5%
Fair Value
$7.28
Current Price
$26.25
$18.97 premium
Margin of Safety
+13.5%
Fair Value
$392.65
Current Price
$335.67
$56.98 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Revenue surging 110.0% year-over-year
Reasonable price relative to book value
Generating 1.3B in free cash flow
Earnings expanding 55.9% YoY
Large-cap with strong market position
Strong operational efficiency at 27.2%
Generating 1.9B in free cash flow
Areas to Watch
Moderate valuation
ROE of 7.8% — below average capital efficiency
5.0% margin — thin
Earnings declined 50.0%
Weak financial health signals
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : PHG
The strongest argument for PHG centers on PEG Ratio, Revenue Growth, Price/Book. Revenue growth of 110.0% demonstrates continued momentum. PEG of 0.36 suggests the stock is reasonably priced for its growth.
Bull Case : SYK
The strongest argument for SYK centers on EPS Growth, Market Cap, Operating Margin. Revenue growth of 11.4% demonstrates continued momentum. PEG of 1.38 suggests the stock is reasonably priced for its growth.
Bear Case : PHG
The primary concerns for PHG are P/E Ratio, Return on Equity, Profit Margin.
Bear Case : SYK
The primary concerns for SYK are Piotroski F-Score, P/E Ratio. A P/E of 41.7x leaves little room for execution misses.
Key Dynamics to Monitor
PHG profiles as a hypergrowth stock while SYK is a value play — different risk/reward profiles.
PHG carries more volatility with a beta of 0.94 — expect wider price swings.
PHG is growing revenue faster at 110.0% — sustainability is the question.
SYK generates stronger free cash flow (1.9B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (67/100 vs 49/100) and 11.4% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Koninklijke Philips NV ADR
HEALTHCARE · MEDICAL DEVICES · USA
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?